Efficacy of Personalized Postoperative Epilepsy Management in Patients with Glioblastoma Utilizing IDH1 Gene Assessment
Gao-Qiang Meng,1,* Shu Chen,2,* Han-Bin Ye,1 Bao-Jun Ma,1 Shuo Tao,3 Zi Ye1 1Department of Neurosurgery, Affiliated Hospital 2 of Nantong University, Nantong First People’s Hospital, Nantong, 226000, People’s Republic of China; 2Department of Endocrinology, Affiliated Hospital 2 of N...
Main Authors: | Meng GQ, Chen S, Ye HB, Ma BJ, Tao S, Ye Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2024-04-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-of-personalized-postoperative-epilepsy-management-in-patients-peer-reviewed-fulltext-article-NDT |
Similar Items
-
Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report
by: Ali S. Haider, et al.
Published: (2023-04-01) -
Study of Surrogate Immunohistochemical Markers IDH1, ATRX, BRAF V600E, and p53 Mutation in Astrocytic and Oligodendroglial Tumors
by: Santosh Sharma, et al.
Published: (2023-08-01) -
A Phase Ib Clinical Trial of Metformin and Chloroquine in Patients with <i>IDH1</i>-Mutated Solid Tumors
by: Mohammed Khurshed, et al.
Published: (2021-05-01) -
<i>IDH</i> Mutations in Glioma: Double-Edged Sword in Clinical Applications?
by: Alisan Kayabolen, et al.
Published: (2021-07-01) -
Expression of IDH1, ATRX, p53 in Diagnosis of Gliomas as Per 2016 WHO Classification
by: Lokesh Kumar, et al.
Published: (2023-07-01)